Concepedia

Annette John-Baptiste

AJ

Statistics

Publications

9

Citations

258

H-Index

9

Active since

2009

Affiliations

Pfizer (United States)(Current)

Annette John-Baptiste is an author at Pfizer (United States) specializing in pharmacology, medicine, and toxicology.

Publications per year

2009–2016

9

Publications

9

Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models

Cathy C. Zhang, Zhengming Yan, Qing Zong et al. · Stem Cells Translational Medicine · 2013 · 91 citations · Full text

, , +17

Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation

Douglas D. Fang, Cathy C. Zhang, Yin Gu et al. · PLoS ONE · 2013 · 45 citations · Full text

, , +16

Evaluation of Potential Gastrointestinal Biomarkers in a PAK4 Inhibitor-treated Preclinical Toxicity Model to Address Unmonitorable Gastrointestinal Toxicity

Annette John-Baptiste, Wenhu Huang, Erick Kindt et al. · Toxicologic Pathology · 2012 · 30 citations

, , +17

Effects of CP-532,623 and Torcetrapib, Cholesteryl Ester Transfer Protein Inhibitors, on Arterial Blood Pressure

Eileen Blasi, M J Bamberger, Delvin R. Knight et al. · Journal of Cardiovascular Pharmacology · 2009 · 22 citations

, , +17

Evaluation of miR-216a and miR-217 as Potential Biomarkers of Acute Exocrine Pancreatic Toxicity in Rats

Jian‐Ying Wang, Wenhu Huang, Stéphane Thibault et al. · Toxicologic Pathology · 2016 · 20 citations

, , +17

1–5 of 9